Uploaded August 2026 | Updated September 2026, 2 weeks ago

---

The CEO of French neurotechnology startup Robeauté says its microrobot could unlock precise delivery of drugs and other therapies directly into the brain,
The microrobots, which are each the size of grain of rice, are able to reach areas that are difficult to access with existing treatments.
Joana Cartocci says the company is targeting first-in-human studies in 2027 and a market launch in the early 2030s.
She spoke to Tom Mackenzie on the latest episode of Bloomberg Tech: Europe.
--------
Like this video? Subscribe to Bloomberg Technology on YouTube:
youtube.com/channel/UCrM7B7SL_g1edFOnmj-SDKg
 
Watch the latest full episodes of "Bloomberg Technology" with Caroline Hyde and Ed Ludlow here:
youtube.com/playlist?list=PLfAX25ZLrPGTygCwn55voYZ_LYyKjxokJ
 
Get the latest in tech from Silicon Valley and around the world here:
bloomberg.com/technology
Connect with us on...
X: twitter.com/technology
Facebook: facebook.com/BloombergTechnology
Instagram: instagram.com/bloombergbusiness
 
Follow Ed Ludlow on X here: twitter.com/EdLudlow
Follow Caroline Hyde on X here: twitter.com/CarolineHydeTV
 
Listen to the daily Bloomberg Technology podcast here:
bloomberg.com/podcasts/series/bloomberg-technology
 
More from Bloomberg Business
Connect with us on...
X: twitter.com/business
Facebook: facebook.com/bloombergbusiness
Instagram: instagram.com/bloombergbusiness
LinkedIn: linkedin.com/company/bloomberg-news
TikTok: tiktok.com/@bloombergbusiness